PRO-PHARMACEUTICALS REPORTS 2006 ACHIEVEMENTS/2007 GOALS.
Pro-Pharmaceuticals, Inc. (Amex: PRW), Newton, Mass., a developer
of novel carbohydrate compounds, is providing a corporate update of its
2006 achievements and 2007 objectives.
Key Highlights
. . .
BURRILL'S BIOTECH OUTLOOK FOR 2007 AND LOOK BACK AT
2006.(Company overview)
"The biotech industry finished the year by giving back over
half the stellar gains earned by its 'blue chip' companies in
2005, a year in which they increased 22%, with the Burrill Biotech
Select . . .
ICON 2007 EPS FORECAST TO GROW 29% COMPARED TO 2006.(Brief
article)
ICON (NASDAQ: ICLR), Dublin, Ireland, a global provider of
outsourced development services to the pharmaceutical, biotechnology and
medical device industries, has raised its existing 2006 guidance . . .
AVANIR REPORTS 4TH QTR FISCAL 2006 NET LOSS OF $22.2 MIL.(AVANIR
Pharmaceuticals)(Financial report)
Pharmaceuticals (NASDAQ:AVNR), San Diego, Calif., has reported
unaudited financial results for the quarter and fiscal year ended
September 30, 2006.
Fourth Quarter 2006 Results
For the fourth . . .
HELIX BIOPHARM REPORTS FIRST QTR FISCAL 2007 LOSS.
Helix BioPharma Corp. (TSX, FSE: "HBP"), Aurora, Ont.,
Canada, has announced financial results for the first quarter of fiscal
2007, ended October 31, 2006.
Highlights
- Initiated enrollment in . . .
PPD NET REVENUE PROJECTED TO GROW 19% IN 2007.
PPD, Inc. (Nasdaq: PPDI), Wilmington, NC, has updated its existing
2006 guidance and reported its projected financial guidance for 2007.
PPD anticipates that net revenue, excluding . . .
AVIGEN REPORTS 3RD QTR NET LOSS OF $5.7 MILLION.
Avigen, Inc. (Nasdaq:AVGN), Alameda, Calif., has reported financial
results for the three and nine months ended September 30, 2006. At
September 30, 2006, Avigen had approximately $75 million in . . .
FISHER SCIENTIFIC 3RD QTR SALES INCREASED MORE THAN 10%.(Company
overview)
Fisher Scientific International Inc. (NYSE: FSH), Hampton, N.H.,
the world leader in serving science, has reported record sales and
earnings for the third quarter ended Sept. 30, 2006, reflecting . . .
VALENTIS REPORTS NET LOSS OF $15.3 MIL FOR FISCAL YEAR.
Valentis, Inc. (NASDAQ:VLTS), Burlingame, Calif., has announced
fiscal 2006 financial results for the fourth quarter and fiscal year
ended June 30, 2006.
Valentis reported a net loss for the year . . .
PACIFIC BIOMETRICS REPORTS 233% REVENUE GROWTH FOR FISCAL
2006.
Pacific Biometrics, Inc. (OTCBB: PBME; "PBI"), Seattle, a
leading provider of specialized central laboratory and contract research
services, released financial results for fiscal 2006. Revenues for . . .
AURIGA PROJECTS $26.4 MIL REVENUE FOR CALENDAR YR 2006.(Auriga
Laboratories )(Company overview)
Auriga Laboratories, Inc. (OTCBB:ARGA), Norcross, Ga., a specialty
pharmaceutical company formed to drive high-growth revenues through
acquisition of valuable brand portfolios and innovative drug . . .
DELTAGEN REPORTS 2006 2ND QTR NET INCOME OF $1.483 MIL.
Deltagen, Inc. (Pink Sheets:DGEN), San Carlos, Calif. a leading
provider of drug discovery tools to the biopharmaceutical industry, has
reported financial results for the three months ended June . . .
INTEGRATED BIOPHARMA REVENUES INCREASE 77% FOR FISCAL
YEAR.
Integrated BioPharma, Inc. (AMEX:INB), Hillside, N.J., has reported
financial results for its fiscal year ended June 30, 2006. Revenues were
$57.8 million, an increase of approximately 77% or $25.1 . . .
HEALTHCARE TECHNOLOGIES HAS 2ND QTR REVENUES OF $3.45
MIL.
Healthcare technologies has reported revenues for the first six
months of 2006 were $7.05 million, compared to $5.89 million for the
first six months of 2005. This reflects an increase of 20% which . . .
CRYOCATH INCREASED 3RD QTR FISCAL REVENUE BY 6% TO $9.7
MIL.(Company overview)
CryoCath Technologies Inc., Montreal, a global leader in
cryotherapy products to treat cardiovascular disease, has announced
financial results for the third quarter ended June 30, 2006.
Selected . . .
EVOTEC 2ND QTR 2006 REVENUES INCREASED BY 2% TO EUR 18.8
MIL.
Evotec AG (ISIN: DE000 5664809, EVT) has reported financial results
for the second quarter 2006. Revenues for the second quarter 2006
increased by 2% to EUR 18.8 million (Q2 2005: EUR 18.4 . . .
CANDELA REPORTS 4TH FISCAL QTR REVENUES OF $41.3 MILLION.
Candela Corporation (NASDAQ: CLZR), Wayland, Mass.,has announced
that revenues for its fourth fiscal quarter and full fiscal year were
$41.3 million and $149.5 million, increases of 7% and 21% when . . .
SEPRACORE REPORTS NET INCOME OF $11.3 MIL FOR 2ND QTR
2006.
Sepracor Inc. (Nasdaq: SEPR), Marlborough, Mass., has announced its
consolidated financial results for the second quarter of 2006. For the
three months ended June 30, 2006, Sepracor's consolidated . . .
IMCLONE REPORTS TOTAL REVENUES OF $149.9 MIL FOR 2ND QTR
'06.
ImClone Systems Incorporated (NASDAQ: IMCL), New York, has
announced its financial results for the quarter and six months ended
June 30, 2006.
Total revenues for the second quarter of 2006 were . . .
BIACORE OVERALL SALES INCREASED 21% IN 2ND QTR OF 2006.
Biacore, Stockholm, Sweden, continued to make very good progress in
the second quarter of 2006. Overall sales increased by 21% to SEK 161.6
million (133.1). This strong performance was again driven . . .
|
|